Mass-producible immune cells kill patient-derived colorectal tumors in mice

Off-the-shelf and mass-producible immune cells fight solid human tumors engrafted into mice. The Kobe University development is a significant contribution towards faster and cheaper cancer immunotherapy.

Raccontata daeurekalert.org